Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 46, Issue 6, 1997, Pages 661-665

  Berg, T J ^a   Bangstad, H J ^b   Torjesen, P A ^b   Osterby R ^b   Bucala, R ^b   Hanssen, K F ^b  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; PLASMA PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BASEMENT MEMBRANE; CHILD; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; GLOMERULUS; GLYCATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SCHOOL CHILD;

EID: 0031008674     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90010-X     Document Type: Article

References (27)

1. Dahl-Jørgensen K: Near-normoglycemia and late diabetic complications. The Oslo Study (thesis). Acta Endocrinol (Copenh) 115:1-56, 1987
2. Hanssen KF, Bangstad H-J, Brinchmann-Hansen O, et al: Blood glucose control and diabetic microvascular complications: Longterm effects of near-normoglycaemia. Diabet Med 9:697-705, 1992
3. Reichard P, Nilsson B-Y, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
4. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. Bangstad H-J, østerby R, Dahl-Jørgensen K, et al: Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37:483-489, 1994
6. 1c in diabetes mellitus. N Engl J Med 295:417-420, 1976
7. Brownlee M, Vlassara H, Cerami A: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
8. Brett J, Schmidt AM, Yan SD, et al: Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143:1699-1711, 1993
9. Schmidt AM, Vianna M, Gerlach M, et al: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267:14987-14997, 1992
10. Vlassara H, Brownlee M, Manogue K, et al: Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodelling. Science 240:1546-1548, 1988
11. Kirstein M, Brett J, Radoff S, et al: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014, 1990
12. Doi T, Vlassara H, Kirstein M, et al: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet derived growth factor. Proc Natl Acad Sci USA 89:2873-2877, 1992
13. Beisswenger PJ, Moore LL, Brinck-Johnsen T, et al: Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92:212-217, 1993
14. Beisswenger PJ, Makita Z, Curphey TJ, et al: Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44:824-829, 1995
15. Bangstad H-J, Østerby R, Dahl-Jorgensen K, et al: Early glomerulopathy is present in young, type I (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 36:523-529, 1993
16. Tilton RG, Chang K, Hasan SH, et al: Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221-232, 1993
17. Makita Z, Vlassara H, Cerami A, et al: Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138, 1992
18. Makita Z, Vlassara H, Rayfield E, et al: Hemoglobin-AGE: A circulating marker of advanced glycosylation. Science 258:651-653, 1992
19. Bucala R, Makita Z, Koschinsky T, et al: Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434-6438, 1993
20. Nakayama H, Taneda S, Mitsuhashi T, et al: Characterization of antibodies to advanced glycosylation end products on protein. J Immunol Methods 140:119-125, 1991
21. Papanastasiou P, Grass L, Rodela H, et al: Immunological quantification of advanced glycosylation end-ptoducts in the serum of patients on hemodialysis or CAPD. Kidney Int 46:216-222, 1994
22. Makita Z, Bucala R, Rayfield EJ, et al: Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 343:1519-1522, 1994
23. McCance DR, Dyer DG, Dunn JA, et al: Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470-2478, 1993
24. Giardino I, Edelstein D, Brownlee M: Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. J Clin Invest 94:110-117, 1994
25. Soulis-Liparota T, Cooper M, Papazoglou D, et al: Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 40:1328-1334, 1991
26. Vlassara H, Striker LJ, Teichberg S, et al: Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci USA 91:11704-11708, 1994
27. Nishino T, Horii Y, Shiki H, et al: Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy. Hum Pathol 26:308-313, 1995